(CON) Concentra Holdings Parent - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US20603L1026
CON EPS (Earnings per Share)
CON Revenue
CON: Occupational, Health, Services, Primary, Care, Preventive, Wellness
Concentra Group Holdings Parent, Inc. (NYSE: CON) is a leading provider of occupational health services in the United States, operating an extensive network of over 500 clinics nationwide. The company offers a comprehensive suite of services tailored to employers and workers, including injury care, primary care, urgent care, preventive care, and wellness programs. Concentras services are designed to address workplace health challenges, with a focus on preventive care, clinical testing, physical examinations, drug and alcohol screenings, and vaccinations. The company also provides telemedicine solutions through Concentra Telemed, enabling remote treatment of work-related injuries and illnesses. Additionally, Concentra offers pharmacy solutions and compliance administration services to manage workplace drug testing programs efficiently.
Founded in 1979 and headquartered in Mechanicsburg, Pennsylvania, Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation. The companys approach combines clinical expertise with a focus on reducing workplace hazards and promoting employee well-being. Concentras services are complemented by a range of consultative programs aimed at enhancing workplace safety and health outcomes. With a strong emphasis on employer-sponsored health services, Concentra has established itself as a key player in the occupational health sector, catering to both regulated and non-regulated industries.
### 3-Month Forecast Based on the providedAdditional Sources for CON Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CON Stock Overview
Market Cap in USD | 2,767m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2024-07-25 |
CON Stock Ratings
Growth Rating | -15.0 |
Fundamental | 31.9 |
Dividend Rating | 33.6 |
Rel. Strength | 7.82 |
Analysts | 4.63 of 5 |
Fair Price Momentum | 20.24 USD |
Fair Price DCF | 29.95 USD |
CON Dividends
Dividend Yield 12m | 0.88% |
Yield on Cost 5y | 0.85% |
Annual Growth 5y | 41.42% |
Payout Consistency | 100.0% |
Payout Ratio | 13.9% |
CON Growth Ratios
Growth Correlation 3m | 15.2% |
Growth Correlation 12m | -19.3% |
Growth Correlation 5y | -19.3% |
CAGR 5y | -2.93% |
CAGR/Max DD 5y | -0.14 |
Sharpe Ratio 12m | -0.64 |
Alpha | -9.90 |
Beta | 0.277 |
Volatility | 34.68% |
Current Volume | 471.3k |
Average Volume 20d | 471.1k |
As of June 01, 2025, the stock is trading at USD 21.63 with a total of 471,286 shares traded.
Over the past week, the price has changed by +2.32%, over one month by -1.23%, over three months by -4.21% and over the past year by -2.93%.
Neither. Based on ValueRay´s Fundamental Analyses, Concentra Holdings Parent is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.86 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CON is around 20.24 USD . This means that CON is currently overvalued and has a potential downside of -6.43%.
Concentra Holdings Parent has received a consensus analysts rating of 4.63. Therefor, it is recommend to buy CON.
- Strong Buy: 5
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CON Concentra Holdings Parent will be worth about 21.9 in June 2026. The stock is currently trading at 21.63. This means that the stock has a potential upside of +1.06%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 28 | 29.4% |
Analysts Target Price | 28 | 29.4% |
ValueRay Target Price | 21.9 | 1.1% |